KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clorox (CLX) EBT (2016 - 2025)

Clorox (CLX) has 17 years of EBT data on record, last reported at $215.0 million in Q4 2025.

  • For Q4 2025, EBT fell 9.28% year-over-year to $215.0 million; the TTM value through Dec 2025 reached $986.0 million, up 52.4%, while the annual FY2025 figure was $1.1 billion, 170.85% up from the prior year.
  • EBT reached $215.0 million in Q4 2025 per CLX's latest filing, up from $107.0 million in the prior quarter.
  • Across five years, EBT topped out at $410.0 million in Q2 2025 and bottomed at -$245.0 million in Q1 2023.
  • Average EBT over 5 years is $134.2 million, with a median of $133.0 million recorded in 2022.
  • Peak YoY movement for EBT: plummeted 222.5% in 2023, then skyrocketed 704.76% in 2025.
  • A 5-year view of EBT shows it stood at $93.0 million in 2021, then skyrocketed by 39.78% to $130.0 million in 2022, then increased by 4.62% to $136.0 million in 2023, then soared by 74.26% to $237.0 million in 2024, then fell by 9.28% to $215.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $215.0 million in Q4 2025, $107.0 million in Q3 2025, and $410.0 million in Q2 2025.